The Brief

The Trump administration has canceled $766 million awarded to drugmaker Moderna Inc. to develop a vaccine against potential pandemic influenza viruses, including the H5N1 bird flu.

The cancellation comes as Moderna announced positive interim results from an early-stage trial of the vaccine that targeted H5 bird flu virus, tested in 300 healthy adults. The funds were awarded through the Biomedical Advanced Research and Development Authority, or BARDA, a program focused on medical treatments for potential pandemics.

Flu virus contract canceled

What they're saying:

Moderna said the Health and Human Services Department, led by vaccine skeptic Robert F. Kennedy Jr., has withdrawn funds awarded in July 2024 and in January to pay for development and purchase of its exploratory va

See Full Page